Literature DB >> 19323953

Control of inflammation with alpha1-antitrypsin: a potential treatment for islet transplantation and new-onset type 1 diabetes.

Gordon C Weir1, Maria Koulamnda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19323953     DOI： 10.1007/s11892-009-0018-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  17 in total

1.  Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts.

Authors:  Maria Koulmanda; Ejona Budo; Susan Bonner-Weir; Andi Qipo; Prabhakar Putheti; Nicolas Degauque; Hang Shi; Zhigang Fan; Jeffrey S Flier; Hugh Auchincloss; Xin Xiao Zheng; Terry B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

2.  Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes.

Authors:  M L Brantly; J T Wittes; C F Vogelmeier; R C Hubbard; G A Fells; R G Crystal
Journal:  Chest       Date:  1991-09       Impact factor: 9.410

Review 3.  Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

Authors:  R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

4.  Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.

Authors:  Eli C Lewis; Leland Shapiro; Owen J Bowers; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

5.  Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects.

Authors:  A Churg; J Dai; K Zay; A Karsan; R Hendricks; C Yee; R Martin; R MacKenzie; C Xie; L Zhang; S Shapiro; J L Wright
Journal:  Lab Invest       Date:  2001-08       Impact factor: 5.662

6.  alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice.

Authors:  Eli C Lewis; Mark Mizrahi; Michel Toledano; Nathaniel Defelice; Joanne L Wright; Andrew Churg; Leland Shapiro; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

7.  Alpha1-antitrypsin protects beta-cells from apoptosis.

Authors:  Bin Zhang; Yuanqing Lu; Martha Campbell-Thompson; Terry Spencer; Clive Wasserfall; Mark Atkinson; Sihong Song
Journal:  Diabetes       Date:  2007-03-14       Impact factor: 9.461

Review 8.  The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders.

Authors:  S N Breit; D Wakefield; J P Robinson; E Luckhurst; P Clark; R Penny
Journal:  Clin Immunol Immunopathol       Date:  1985-06

9.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.

Authors:  Volkert A L Huurman; Robert Hilbrands; Gabriëlle G M Pinkse; Pieter Gillard; Gaby Duinkerken; Pieter van de Linde; Petronella M W van der Meer-Prins; Minke F J Versteeg-van der Voort Maarschalk; Koen Verbeeck; Behrooz Z Alizadeh; Chantal Mathieu; Frans K Gorus; Dave L Roelen; Frans H J Claas; Bart Keymeulen; Daniel G Pipeleers; Bart O Roep
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240
View more
  6 in total

1.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

2.  Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment.

Authors:  Gopalakrishnan Loganathan; Rajinder K Dawra; Subbiah Pugazhenthi; Zhiguang Guo; Sajjad M Soltani; Alexander Wiseman; Mark A Sanders; Klearchos K Papas; Kumaravel Velayutham; Ashok K Saluja; David E R Sutherland; Bernhard J Hering; A N Balamurugan
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

3.  Human α1-antitrypsin modifies B-lymphocyte responses during allograft transplantation.

Authors:  Mark Mizrahi; Pablo Cal; Martin Rosenthal; David Ochayon; Galit Shahaf; Ziv Kaner; Peter Kachker; Eli C Lewis
Journal:  Immunology       Date:  2013-11       Impact factor: 7.397

Review 4.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

5.  The immunoregulation effect of alpha 1-antitrypsin prolong β-cell survival after transplantation.

Authors:  Yun Wang; Hong-Jie Yan; Shu-Yan Zhou; Yun-Shuang Wang; Hui Qi; Chun-Yan Deng; Fu-Rong Li
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

6.  Human plasma-derived alpha1 -proteinase inhibitor in patients with new-onset type 1 diabetes mellitus: A randomized, placebo-controlled proof-of-concept study.

Authors:  William H Lagarde; Kecia L Courtney; Barry Reiner; Kimberly Steinmann; Eva Tsalikian; Steven M Willi
Journal:  Pediatr Diabetes       Date:  2020-12-13       Impact factor: 4.866
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.